Protalix BioTherapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $44.5M | $38.3M | $6.2M | $2.7M |
| FY2010 | $-38.5M | $-46.3M | $7.9M | $1.3M |
| FY2011 | $-23.6M | $-29.3M | $5.7M | $886.0K |
| FY2012 | $635.0K | $-1.4M | $2.1M | $7.8M |
| FY2013 | $-30.7M | $-32.5M | $1.9M | $4.1M |